Skip to main content
. Author manuscript; available in PMC: 2013 Feb 28.
Published in final edited form as: Psychol Med. 2011 Feb 9;41(9):1879–1888. doi: 10.1017/S003329171100016X

Table 2.

Univariate Repeated Measures Associations of Baseline and Annual Measures with Odds of a Major Depressive Episode from Baseline Through Visit 9

OR 95% CI p-value
Baseline characteristics
Age 1.10 (1.03, 1.17) 0.005
African American 1.62 (0.76, 3.46) 0.21
History of major depressive disorder 4.51 (2.20, 9.25) <.0001
Annual measures
Menopausal status (referent category: premenopause)
      Perimenopause 2.17 (1.23, 3.81) 0.007
      Postmenopause 3.43 (1.79, 6.56) <.0001
Hormone therapy use 1.20 (0.38, 3.73) 0.76
Vasomotor symptoms ≥6days/past 2 weeks (hot flashes or night sweats) 2.50 (1.48, 4.22) 0.001
BMI 1.08 (1.02, 1.13) 0.004
Log E2** 0.82 (0.63, 1.06) 0.13
Log T** 1.04 (0.62, 1.74) 0.90
Log FSH** 1.25 (.97, 1.62) 0.08
Change in E2 from baseline* 1.00 (1.00, 1.00) 0.57
Change in Testosterone from baseline* 1.01 (1.00, 1.03) 0.10
Change in FSH from baseline* 1.00 (0.99, 1.01) 0.90
*

Adjusted for baseline value

**

Note: The results for hormones were similar when adjusted for BMI.